Chirality of a 1,10-bisacetoxy-mitosene compound. Impact on reductive activation, DNA interstrand crosslinking, and antitumour activity

M. Maliepaard; P.C. Groot; N.J. de Mol; L.H.M. Janssen; M. Freriks; W. Verboom; D.N. Reinhoudt; M. Stephens; I.J. Stratford

Chirality of a 1,10-bisacetoxy-mitosene compound. Impact on reductive activation, DNA interstrand crosslinking, and antitumour activity

M. Maliepaard
, P.C. Groot
, N.J. de Mol
, L.H.M. Janssen
, M. Freriks
, W. Verboom
, D.N. Reinhoudt
, M. Stephens
, I.J. Stratford

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	403-413
Number of pages	11
Journal	Anti-Cancer Drug Design
Volume	11
Publication status	Published - 1996

Keywords

Biophysics
Farmacie(FARM)
Farmaceutische produkten
Occupational medicine
Biomedische technologie en medicijnen
Nutrition sciences

Cite this

@article{1e6c09cd57454313a92f5d505fa0346f,

title = "Chirality of a 1,10-bisacetoxy-mitosene compound. Impact on reductive activation, DNA interstrand crosslinking, and antitumour activity",

keywords = "Biophysics, Farmacie(FARM), Farmaceutische produkten, Occupational medicine, Biomedische technologie en medicijnen, Nutrition sciences",

author = "M. Maliepaard and P.C. Groot and \{de Mol\}, N.J. and L.H.M. Janssen and M. Freriks and W. Verboom and D.N. Reinhoudt and M. Stephens and I.J. Stratford",

year = "1996",

language = "Undefined/Unknown",

volume = "11",

pages = "403--413",

journal = "Anti-Cancer Drug Design",

issn = "0266-9536",

publisher = "Cognizant Communication Corporation",

}

TY - JOUR

T1 - Chirality of a 1,10-bisacetoxy-mitosene compound. Impact on reductive activation, DNA interstrand crosslinking, and antitumour activity

AU - Maliepaard, M.

AU - Groot, P.C.

AU - de Mol, N.J.

AU - Janssen, L.H.M.

AU - Freriks, M.

AU - Verboom, W.

AU - Reinhoudt, D.N.

AU - Stephens, M.

AU - Stratford, I.J.

PY - 1996

Y1 - 1996

KW - Biophysics

KW - Farmacie(FARM)

KW - Farmaceutische produkten

KW - Occupational medicine

KW - Biomedische technologie en medicijnen

KW - Nutrition sciences

M3 - Article

SN - 0266-9536

VL - 11

SP - 403

EP - 413

JO - Anti-Cancer Drug Design

JF - Anti-Cancer Drug Design

ER -